Heartland Advisors highlighted Bentley Systems as a new buy, noting its discounted stock price despite strong long-term prospects. Watsco's acquisition of two family-run businesses is expected to boost revenue and cash flow by about 10%. The firm remains confident in MarketAxess due to its exit from a heavy investment cycle, which should improve operating leverage. Despite these positives, Heartland's Mid Cap Value Fund fell 4.77% in Q3, underperforming the Russell Midcap® Value Index.
Heartland Mid Cap Value Fund Q3 2026 portfolio activity is shown here with Pluang's Financials sector data for context. Of 118 priced Financials stocks on Pluang, 52 rose and 65 fell as of Oct 13, 2026 22:41 WIB. Notable movers include WULF at USD 12.81 with a 1-day change of -4.19% and 96% buy orders, FIGR at USD 27.35 down 3.90%, and HUT at USD 81.98 down 3.82% with 93% sell orders.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
